Invesco
ENFN

Invesco’s Enfusion, Inc. ENFN Stock Holding History

Invesco’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,375
Closed -$294K – 3907
2025
Q1 		$294K Buy
26,375
+13,550
+106% +$150K ﹤0.01% 3363
2024
Q4 		$132K Buy
12,825
+722
+6% +$6.98K ﹤0.01% 3589
2024
Q3 		$115K Buy
12,103
+265
+2% +$2.29K ﹤0.01% 3599
2024
Q2 		$101K Buy
11,838
+1,348
+13% +$12.3K ﹤0.01% 3750
2024
Q1 		$97K Buy
10,490
+359
+4% +$3.16K ﹤0.01% 3745
2023
Q4 		$98.3K Sell
10,131
-2,116
-17% -$19.8K ﹤0.01% 3689
2023
Q3 		$110K Buy
12,247
+2,147
+21% +$20.4K ﹤0.01% 3706
2023
Q2 		$113K Sell
10,100
-81
-0.8% -$718 ﹤0.01% 3706
2023
Q1 		$107K Buy
+10,181
New +$112K ﹤0.01% 3699
2022
Q4 		– Sell
-10,687
Closed -$132K – 4073
2022
Q3 		$132K Buy
+10,687
New +$130K ﹤0.01% 3786

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Invesco's ENFN Position: Q2 2025 in Review

Invesco sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 26,375 shares — an estimated $294K sold.

Invesco first reported a position in ENFN in Q3 2022 and held it in 10 quarters. The position peaked at $294K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Invesco reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 26,375 Enfusion, Inc. shares in Q2 2025, an estimated $294K.
  • Invesco first reported a position in Enfusion, Inc. in Q3 2022 and held it in 10 quarters.
  • Invesco's Enfusion, Inc. position peaked at $294K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.